Vera Therapeutics VERA Proceeds From Borrowings Net Of Costs
Proceeds From Borrowings Net Of Costs at other companies
Other financials
Where this comes from
Reported directly by Vera Therapeutics in its filing.
Tagged under the XBRL concept vera:ProceedsFromBorrowingsNetOfCosts.
The official record: Vera Therapeutics’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vera Therapeutics's proceeds from borrowings net of costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vera Therapeutics's proceeds from borrowings net of costs?
- Vera Therapeutics (VERA) reported proceeds from borrowings net of costs of $0 in Q4 2025.
- What is the long-term trend for Vera Therapeutics's proceeds from borrowings net of costs?
- Over 4 years (2021 to 2025), Vera Therapeutics's proceeds from borrowings net of costs has grown at a -100.0% compound annual growth rate (CAGR), from $4.92M to $0.
- What does proceeds from borrowings net of costs mean?
- This represents the net cash received from debt financing activities after deducting all associated issuance and transaction costs. It provides a clear view of the actual liquidity added to the balance sheet through debt instruments. This metric is critical for assessing the company's ability to raise capital through credit markets.